Astellas Skirts $867M Antitrust Suit Over Heart Test Drug
A federal judge ruled Monday that a Florida hospital didn't have standing to file an $867 million antitrust class action accusing Astellas Pharma Inc. of abusing a patent monopoly to force...To view the full article, register now.
Already a subscriber? Click here to view full article